MegaPro Biomedical Co EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MegaPro Biomedical Co is -119.59 M TWD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of MegaPro Biomedical Co changed from -180.19 M TWD to -119.59 M TWD, representing a -33.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) MegaPro Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s MegaPro Biomedical Co historically and in real time.